Insider trading
Purchases, sales and option exercises by company officers, directors and 10% owners, as reported to the SEC on Form 4.
- Insider purchases
- $141.81M
- 291 open-market buys, last 14 days
- Insider sales
- $599.59M
- 640 open-market sales, last 14 days
- Buy / sell ratio
- 0.24
- Dollar value bought per dollar sold
- Cluster buys
- 6
- Symbols bought by 2+ insiders
Cluster buys
Two or more insiders buying
Largest insider buying
Open-market purchases by value
Largest insider selling
Open-market sales by value
293 transactions · Oct 20 – Nov 2
| Date | Symbol | Insider | Type | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 22 | USNA USANA Health Sciences, Inc. | Fleming John Turman Director | Exercise | 1,632 | — | — | 3.26K | Form 4filing for Fleming John Turman (opens SEC.gov) |
| Oct 22 | USNA USANA Health Sciences, Inc. | FULLER GILBERT A Director | Exercise | 1,632 | — | — | 3.26K | Form 4filing for FULLER GILBERT A (opens SEC.gov) |
| Oct 22 | USNA USANA Health Sciences, Inc. | Nixon J Scott Director | Exercise | 1,632 | — | — | 3.26K | Form 4filing for Nixon J Scott (opens SEC.gov) |
| Oct 22 | USNA USANA Health Sciences, Inc. | Pelosi Peggie Director | Exercise | 1,632 | — | — | 3.26K | Form 4filing for Pelosi Peggie (opens SEC.gov) |
| Oct 22 | USNA USANA Health Sciences, Inc. | Winssinger Frederic J Director | Exercise | 1,632 | — | — | 3.26K | Form 4filing for Winssinger Frederic J (opens SEC.gov) |
| Oct 22 | USNA USANA Health Sciences, Inc. | WOOD TIMOTHY E Director | Exercise | 1,632 | — | — | 3.26K | Form 4filing for WOOD TIMOTHY E (opens SEC.gov) |
| Oct 22 | UTHR United Therapeutics Corporation | ROTHBLATT MARTINE A Director, Chairperson & CEO | Exercise | 9,500 | — | — | 176.41K | Form 4filing for ROTHBLATT MARTINE A (opens SEC.gov) |
| Oct 22 | ZETA Zeta Global Holdings Corp. | Gerber Steven H. President | Exercise | 60,849 | — | — | 0 | Form 4filing for Gerber Steven H. (opens SEC.gov) |
| Oct 22 | ZETA Zeta Global Holdings Corp. | Greiner Christopher E Chief Financial Officer | Exercise | 53,181 | — | — | 0 | Form 4filing for Greiner Christopher E (opens SEC.gov) |
| Oct 22 | ZETA Zeta Global Holdings Corp. | Ravella Satish Chief Accounting Officer | Exercise | 6,017 | — | — | 0 | Form 4filing for Ravella Satish (opens SEC.gov) |
| Oct 22 | ZETA Zeta Global Holdings Corp. | Steinberg David Director, 10% owner, Chief Executi | Exercise | 132,961 | — | — | 0 | Form 4filing for Steinberg David (opens SEC.gov) |
| Oct 21 | TRV The Travelers Companies, Inc. | Schnitzer Alan D Director, Chairman and CEO | Exercise | 298,368 | 132.58 | $39.56M | 0 | Form 4filing for Schnitzer Alan D (opens SEC.gov) |
| Oct 21 | SE Sea Limited | Feng Zhimin President | Exercise | 1,000,000 | 15.00 | $15.00M | 2.00M | Form 4filing for Feng Zhimin (opens SEC.gov) |
| Oct 21 | CRL Charles River Laboratories International, Inc. | Parisotto Shannon M CEVP, Disc & Safety Assessment | Exercise | 2,156 | 244.41 | $526.95K | 719 | Form 4filing for Parisotto Shannon M (opens SEC.gov) |
| Oct 21 | MEDP Medpace Holdings, Inc. | BURWIG SUSAN E Exec. VP, Operations | Exercise | 2,700 | 166.73 | $450.17K | 328 | Form 4filing for BURWIG SUSAN E (opens SEC.gov) |
| Oct 21 | SNX TD SYNNEX Corporation | POLK DENNIS Director, Chair, Hyve Solutions | Exercise | 2,905 | 107.32 | $311.76K | 0 | Form 4filing for POLK DENNIS (opens SEC.gov) |
| Oct 21 | ADPT Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE President and COO | Exercise | 11,881 | 12.14 | $144.24K | 201.56K | Form 4filing for RUBINSTEIN JULIE (opens SEC.gov) |
| Oct 21 | AGIO Agios Pharmaceuticals, Inc. | Gheuens Sarah Chief Medical Officer | Exercise | 1,489 | 25.01 | $37.24K | 24.64K | Form 4filing for Gheuens Sarah (opens SEC.gov) |
| Oct 21 | GH Guardant Health, Inc. | MIGNONE ROBERTO Director | Exercise | 264 | — | — | 6.34K | Form 4filing for MIGNONE ROBERTO (opens SEC.gov) |
| Oct 21 | PKBK Parke Bancorp, Inc. | PANTILIONE VITO S Director, President & CEO | Exercise | 500 | — | — | 2.00K | Form 4filing for PANTILIONE VITO S (opens SEC.gov) |
| Oct 21 | PVLA Palvella Therapeutics, Inc. | Goin Kathleen Chief Operating Officer | Exercise | 2,148 | — | — | 0 | Form 4filing for Goin Kathleen (opens SEC.gov) |
| Oct 21 | UTHR United Therapeutics Corporation | ROTHBLATT MARTINE A Director, Chairperson & CEO | Exercise | 9,500 | — | — | 185.91K | Form 4filing for ROTHBLATT MARTINE A (opens SEC.gov) |
| Oct 20 | CHFW-UN Consonance-HFW Acquisition Corp. | COLUMN GROUP III GP, LP 10% owner | Exercise | 775,861 | 11.60 | $9.00M | 0 | Form 4filing for COLUMN GROUP III GP, LP (opens SEC.gov) |
| Oct 20 | CHFW-UN Consonance-HFW Acquisition Corp. | Kutzkey Tim Director, 10 percent owner: | Exercise | 775,861 | 11.60 | $9.00M | 0 | Form 4filing for Kutzkey Tim (opens SEC.gov) |
| Oct 20 | SRZN Surrozen, Inc. | COLUMN GROUP III GP, LP 10% owner | Exercise | 775,861 | 11.60 | $9.00M | 0 | Form 4filing for COLUMN GROUP III GP, LP (opens SEC.gov) |
| Oct 20 | SRZN Surrozen, Inc. | Kutzkey Tim Director, 10 percent owner: | Exercise | 775,861 | 11.60 | $9.00M | 0 | Form 4filing for Kutzkey Tim (opens SEC.gov) |
| Oct 20 | CVX Chevron Corporation | Pate R. Hewitt Chief Legal Officer | Exercise | 40,700 | 132.69 | $5.40M | 0 | Form 4filing for Pate R. Hewitt (opens SEC.gov) |
| Oct 20 | TRV The Travelers Companies, Inc. | Klein Michael Frederick EVP & President, Personal Ins. | Exercise | 7,500 | 139.83 | $1.05M | 22.54K | Form 4filing for Klein Michael Frederick (opens SEC.gov) |
| Oct 20 | RBCAA Republic Bancorp, Inc. | Powell Anthony T EVP, CHIEF LENDING OFFICER | Exercise | 5,376 | 42.74 | $229.77K | 0 | Form 4filing for Powell Anthony T (opens SEC.gov) |
| Oct 20 | ADPT Adaptive Biotechnologies Corporation | RUBINSTEIN JULIE President and COO | Exercise | 11,881 | 12.14 | $144.24K | 213.44K | Form 4filing for RUBINSTEIN JULIE (opens SEC.gov) |
| Oct 20 | ORIC ORIC Pharmaceuticals, Inc. | Piscitelli Dominic Chief Financial Officer | Exercise | 14,000 | 4.36 | $61.04K | 64.50K | Form 4filing for Piscitelli Dominic (opens SEC.gov) |
| Oct 20 | BSVN Bank7 Corp. | Mathews Darrell Lee Jr. Executive Vice President | Exercise | 1,750 | 18.49 | $32.36K | 0 | Form 4filing for Mathews Darrell Lee Jr. (opens SEC.gov) |
| Oct 20 | UNTY Unity Bancorp, Inc. | Maricondo Peter E Director | Exercise | 1,600 | 15.70 | $25.12K | 16.80K | Form 4filing for Maricondo Peter E (opens SEC.gov) |
| Oct 20 | AEHR Aehr Test Systems, Inc. | POSEDEL RHEA J Director: Director | Exercise | 18,000 | — | — | 0 | Form 4filing for POSEDEL RHEA J (opens SEC.gov) |
| Oct 20 | BIO Bio-Rad Laboratories, Inc. | EVRAN SEDAT EVP, Global Supply Chain | Exercise | 1,044 | — | — | 1.04K | Form 4filing for EVRAN SEDAT (opens SEC.gov) |
| Oct 20 | CYTK Cytokinetics, Incorporated | Malik Fady Ibraham EVP Research & Development | Exercise | 3,500 | — | — | 16.39K | Form 4filing for Malik Fady Ibraham (opens SEC.gov) |
| Oct 20 | FA First Advantage Corporation | Nairne Douglas Global Chief Operating Officer | Exercise | 7,000 | — | — | 0 | Form 4filing for Nairne Douglas (opens SEC.gov) |
| Oct 20 | FRVO Fervo Energy Company | Jewett Sarah Allison Chief Operating Officer | Exercise | 59,125 | — | — | 264.60K | Form 4filing for Jewett Sarah Allison (opens SEC.gov) |
| Oct 20 | NMCO Nuveen Municipal Credit Opportunities Fund | Jones Nathaniel T. Vice President | Exercise | 1,800 | — | — | 0 | Form 4filing for Jones Nathaniel T. (opens SEC.gov) |
| Oct 20 | PI Impinj, Inc. | Valdez Arthur L Jr Director | Exercise | 1,220 | — | — | 0 | Form 4filing for Valdez Arthur L Jr (opens SEC.gov) |
| Oct 20 | SRZNW Surrozen, Inc. | COLUMN GROUP III GP, LP 10% owner | Exercise | 775,861 | — | — | 0 | Form 4filing for COLUMN GROUP III GP, LP (opens SEC.gov) |
| Oct 20 | SRZNW Surrozen, Inc. | Kutzkey Tim Director, 10 percent owner: | Exercise | 775,861 | — | — | 0 | Form 4filing for Kutzkey Tim (opens SEC.gov) |
| Oct 20 | WDC Western Digital Corporation | Tregillis Cynthia L Chief Legal Officer & Corp Sec | Exercise | 14 | — | — | 283 | Form 4filing for Tregillis Cynthia L (opens SEC.gov) |
Source: SEC Form 4 filings. Value is shares × reported price; option exercises are often reported without a price. Awards, gifts and tax-withholding transactions are not shown. Not investment advice.